These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Molecular imaging of atherosclerosis in translational medicine. Perrone-Filardi P; Dellegrottaglie S; Rudd JH; Costanzo P; Marciano C; Vassallo E; Marsico F; Ruggiero D; Petretta MP; Chiariello M; Cuocolo A Eur J Nucl Med Mol Imaging; 2011 May; 38(5):969-75. PubMed ID: 21174089 [TBL] [Abstract][Full Text] [Related]
45. Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Leuschner F; Nahrendorf M Circ Res; 2011 Mar; 108(5):593-606. PubMed ID: 21372291 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization. Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368 [TBL] [Abstract][Full Text] [Related]
47. PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology. Evans NR; Tarkin JM; Chowdhury MM; Warburton EA; Rudd JH Curr Atheroscler Rep; 2016 Jun; 18(6):30. PubMed ID: 27108163 [TBL] [Abstract][Full Text] [Related]
48. Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using ¹⁸F-fluoromisonidazole positron emission tomographic imaging. Mateo J; Izquierdo-Garcia D; Badimon JJ; Fayad ZA; Fuster V Circ Cardiovasc Imaging; 2014 Mar; 7(2):312-20. PubMed ID: 24508668 [TBL] [Abstract][Full Text] [Related]
49. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576 [TBL] [Abstract][Full Text] [Related]
50. Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging. Ripa RS; Kjær A Biomed Res Int; 2015; 2015():914516. PubMed ID: 25695091 [TBL] [Abstract][Full Text] [Related]
58. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis. Bucerius J; Hyafil F; Verberne HJ; Slart RH; Lindner O; Sciagra R; Agostini D; Übleis C; Gimelli A; Hacker M; Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):780-92. PubMed ID: 26678270 [TBL] [Abstract][Full Text] [Related]
59. Imaging the Intersection of Oxidative Stress, Lipids, and Inflammation: Progress Toward Personalized Care of Atherosclerosis. Tawakol A; Jaffer F J Am Coll Cardiol; 2018 Jan; 71(3):336-338. PubMed ID: 29348026 [No Abstract] [Full Text] [Related]
60. Imaging atherosclerosis with F18-fluorodeoxyglucose positron emission tomography: What are we actually seeing? Wu JC; Nguyen PK J Am Coll Cardiol; 2011 Aug; 58(6):615-7. PubMed ID: 21798424 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]